AI assistant
DarioHealth Corp. — Director's Dealing 2017
Oct 25, 2017
34711_dirs_2017-10-25_16ac405d-9b06-41e9-a81c-2c9beadc0ecb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DarioHealth Corp. (DRIO)
CIK: 0001533998
Period of Report: 2017-10-23
Reporting Person: Raphael Erez (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-23 | Common Stock | A | 21128 | — | Acquired | 459864 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 757509 | Indirect |
Footnotes
F1: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2017 in the amount of $39,221.54.
F2: The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.